Literature DB >> 16103258

Selective cyclooxygenase-2 inhibitors development in cardiovascular medicine.

Domenico Praticò1, Jean-Michel Dogné.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16103258     DOI： 10.1161/CIRCULATIONAHA.104.524231

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

1.  Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1.

Authors:  Rocchina Colucci; Matteo Fornai; Emiliano Duranti; Luca Antonioli; Ilaria Rugani; Fatma Aydinoglu; Chiara Ippolito; Cristina Segnani; Nunzia Bernardini; Stefano Taddei; Corrado Blandizzi; Agostino Virdis
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 2.  Obesity and Cardiometabolic Defects in Heart Failure Pathology.

Authors:  Ganesh V Halade; Vasundhara Kain
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

Review 3.  Clinical use and pharmacological properties of selective COX-2 inhibitors.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-11-13       Impact factor: 2.953

4.  Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor.

Authors:  L Zhao; T Ding; T Cyrus; Y Cheng; H Tian; M Ma; R Falotico; D Praticò
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

5.  Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia.

Authors:  Allon Wagner; Noa Cohen; Thomas Kelder; Uri Amit; Elad Liebman; David M Steinberg; Marijana Radonjic; Eytan Ruppin
Journal:  Mol Syst Biol       Date:  2015-03       Impact factor: 11.429

6.  Design, synthesis and preliminary pharmacological evaluation of new non-steroidal anti-inflammatory agents having a 4-(methylsulfonyl) aniline pharmacophore.

Authors:  Monther Faisel Mahdi; Mohamed Hassan Mohammed; Akeel Abdul Kadhum Jassim
Journal:  Molecules       Date:  2012-02-10       Impact factor: 4.411

Review 7.  Progress in PET Imaging of Neuroinflammation Targeting COX-2 Enzyme.

Authors:  Jaya Prabhakaran; Andrei Molotkov; Akiva Mintz; J John Mann
Journal:  Molecules       Date:  2021-05-27       Impact factor: 4.411

8.  Selective cyclooxygenase-2 inhibition protects against myocardial damage in experimental acute ischemia.

Authors:  Alberto Carnieto; Paulo Magno Martins Dourado; Protásio Lemos da Luz; Antonio Carlos Palandri Chagas
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

9.  Discrimination of Naturally-Occurring 2-Arylbenzofurans as Cyclooxygenase-2 Inhibitors: Insights into the Binding Mode and Enzymatic Inhibitory Activity.

Authors:  Ericsson Coy-Barrera
Journal:  Biomolecules       Date:  2020-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.